Work

PBMCs as a surrogate marker for tumors: A compilation of Phase I/II trials involving the HDAC inhibitor, valproic acid.

Year: 2007

Type: article

Source: Molecular Cancer Therapeutics

Authors: Morgen Schmitt, Douglas C. Marchion, Elona Biçaku, Pamela N. Münster

Institution: Moffitt Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2343421709

FWCI:

Cites:

Cited by:

Related to: 10